🔗 Permalink

Inventor profile of:

Helmut Buschmann

City:

Aachen

Country:

Germany

Published Applications:

Last publication date:

2025-03-13

Top Assignees for applications by Helmut Buschmann

The entities that hold a legal rights for patent applications filed by inventor Buschmann Helmut:

European Molecular Biology Laboratory 8 Heidelberg, Germany
F. Hoffmann-La Roche AG 6 Basel, Switzerland
SAVIRA PHARMACEUTICALS GMBH 6 Vienna, Austria
AIC246 AG & Co. KG 5 Wuppertal, Germany
Gruenenthal GmbH 4 Aachen, Germany
Savira pharmaceuticals GmbH 2 Vienna, Australia
F. HOFFMAN-LA ROCHE AG 2 Basel, Switzerland
RD&C Research, Development & Consulting GmbH 1 Wien, Austria
AIC246 AG & CO. KG 1 Wuppertal, Germany
LABORATORIOS DEL DR. ESTEVE, S.A. 1 Barcelona, Spain
RD&CResearch, Development &Consulting GmbH 1 Vienna, Austria
LABORATORIES DEL DR. ESTEVE S.A. 1 Barcelona, Spain
European Molecular Biology Laboratory 1 Heidelberg, Switzerland

Recent patent applications by Buschmann Helmut

Helmut Buschmann from Aachen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-13

US20250082637A1

Human necessities

Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)pi-perazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and potassium ions

#2 | 2023-07-13

US20230219900A1

Chemistry; metallurgy

Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate monohydrate, its preparation and use

#3 | 2023-07-13

US20230219899A1

Chemistry; metallurgy

A METHOD OF PRODUCING A CRYSTALLINE FORM OF SODIUM 2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLINE-4-YL]ACETATE TRIHYDRATE

#4 | 2023-05-18

US20230150950A1

Chemistry; metallurgy

Potassium salt of 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid

#5 | 2023-05-04

US20230138444A1

Human necessities

Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and sodium ions

#6 | 2023-03-30

US20230095980A1

Human necessities

Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and pharmaceutical compositions thereof

#7 | 2021-07-01

US20210197181A1

Performing operations; transporting

Kits comprising containers with at least one solid catalytically active compound, and their uses in solid state reaction

#8 | 2017-10-12

US20170290834A1

Human necessities

Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral disease

#9 | 2017-04-13

US20170100396A1

Human necessities

PYRROLOPYRAZINE DERIVATIVES FOR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA

#10 | 2017-03-23

US20170081331A1

Chemistry; metallurgy

Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral disease

#11 | 2017-03-23

US20170081324A1

Chemistry; metallurgy

Triazolones derivatives and their use in the treatment, amelioration or prevention of a viral disease

#12 | 2017-03-23

US20170081323A1

Chemistry; metallurgy

Triazolones derivatives for use in the treatment, amelioration or prevention of a viral disease

#13 | 2017-01-05

US20170000788A1

Human necessities

Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease

#14 | 2016-12-22

US20160367557A1

Human necessities

HETEROCYCLIC PYRIMIDINE CARBONIC ACID DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE

#15 | 2016-12-15

US20160362423A1

Chemistry; metallurgy

7-OXO-THIAZOLOPYRIDINE CARBONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE

#16 | 2016-02-11

US20160039818A1

Chemistry; metallurgy

Substituted 1,5-naphthyridines as endonuclease inhibitors

#17 | 2016-01-07

US20160002227A1

Chemistry; metallurgy

Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease

#18 | 2016-01-07

US20160002226A1

Chemistry; metallurgy

PYRIDOPYRAZINE COMPOUNDS AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA

#19 | 2014-07-10

US20140194476A1

Chemistry; metallurgy

Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral disease

#20 | 2014-07-10

US20140194432A1

Chemistry; metallurgy

Substituted naphthyridines for the treatment, amelioration or prevention of a viral disease

#21 | 2014-07-10

US20140194431A1

Chemistry; metallurgy

Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease

#22 | 2014-02-06

US20140038990A1

Chemistry; metallurgy

Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease

#23 | 2013-11-28

US20130317022A1

Chemistry; metallurgy

7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease

#24 | 2013-11-28

US20130317021A1

Chemistry; metallurgy

HETEROCYCLIC PYRIMIDINE CARBONIC ACID DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE

#25 | 2010-07-22

US20100184772A1

Chemistry; metallurgy

Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators

#26 | 2007-09-25

US10402260

Substituted C-cyclohexylmethylamine derivatives

#27 | 2007-01-30

US10203031

Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives

#28 | 2006-04-04

US10401020

Substituted 1-aminobutan-3-ol compounds

#29 | 2005-05-10

US10189184

Aminomethyl-phenyl-cyclohexanone derivatives

InventorID:

549067 ⎘